Selected category: phenotypic screening

By Simon Fogarty

If you’ve decided you need to incorporate phenotypic screening into your discovery program and you know that one of the new generation of automation platforms is the way forward, what factors should influence your choice?

...

By Simon Fogarty

A main presentation track at SLAS2018 entitled "Cellular Technologies" will include the session "Development of Cellular Models for Phenotypic Screening," chaired by Kristen Brennand, Ph.D., New York Stem Cell Foundation-Robertson...

By Kevin Moore

Phenotypic screening is back, with exciting implications for the discovery of new and more effective drugs. The reason? Constantly improving cellular technologies and instrumentation, and drug discovery and development programs...

by Simon Fogarty

Now that phenotypic screening is well and truly back, how do you take advantage of its many benefits, especially if you’ve already made a considerable commitment to target-based screening? The simple answer is: you combine the two.